Singh Yuvraj, Durga Rao Viswanadham K K, Kumar Jajoriya Arun, Meher Jaya Gopal, Raval Kavit, Jaiswal Swati, Dewangan Jayant, Bora H K, Rath Srikanta Kumar, Lal Jawahar, Mishra Durga Prasad, Chourasia Manish K
Pharmaceutics Division, CSIR-Central Drug Research Institute , Lucknow 226031, India.
Endocrinology Division, CSIR-Central Drug Research Institute , Lucknow 226031, India.
Mol Pharm. 2017 Aug 7;14(8):2749-2765. doi: 10.1021/acs.molpharmaceut.7b00310. Epub 2017 Jul 5.
PLGA was functionalized with PEG and biotin using click chemistry to generate a biotin receptor targeted copolymer (biotinylated-PEG-PLGA) which in turn was used to fabricate ultrafine nanoparticles (BPNP) of doxorubicin hydrochloride (DOX) for effective delivery in 4T1 cell induced breast cancer. However, adequate entrapment of a hydrophilic bioactive like DOX in a hydrophobic polymer system made of PLGA is not usually possible. We therefore modified a conventional W/O/W emulsion method by utilizing NHCl in the external phase to constrain DOX in dissolved polymer phase by suppressing DOX's inherent aqueous solubility as per common ion effect. This resulted in over 8-fold enhancement in entrapment efficiency of DOX inside BPNP, which otherwise is highly susceptible to leakage due to its relatively high aqueous solubility. TEM and DLS established BPNP to be sized below 100 nm, storage stability studies showed that BPNP were stable for one month at 4 °C, and in vitro release suggested significant control in drug release. Extensive in vitro and in vivo studies were conducted to propound anticancer and antiproliferative activity of BPNP. Plasma and tissue distribution study supplemented by pertinent in vivo fluorescence imaging mapped the exact fate of DOX contained inside BPNP once it was administered intravenously. A comparative safety profile via acute toxicity studies in mice was also generated to out rightly establish usefulness of BPNP. Results suggest that BPNP substantially enhance anticancer activity of DOX while simultaneously mitigating its toxic potential due to altered spatial and temporal presentation of drug and consequently deserve further allometric iteration.
使用点击化学将聚乳酸-羟基乙酸共聚物(PLGA)用聚乙二醇(PEG)和生物素进行功能化,以生成靶向生物素受体的共聚物(生物素化-PEG-PLGA),进而用于制备盐酸多柔比星(DOX)的超细纳米颗粒(BPNP),用于在4T1细胞诱导的乳腺癌中有效递送。然而,在由PLGA制成的疏水性聚合物体系中充分包封像DOX这样的亲水性生物活性物质通常是不可能的。因此,我们改进了传统的W/O/W乳液法,通过在外相中使用氯化铵,根据同离子效应抑制DOX固有的水溶性,将DOX限制在溶解的聚合物相中。这导致BPNP中DOX的包封效率提高了8倍以上,否则由于其相对较高的水溶性,DOX极易泄漏。透射电子显微镜(TEM)和动态光散射(DLS)确定BPNP的尺寸小于100 nm,储存稳定性研究表明BPNP在4℃下可稳定保存一个月,体外释放表明药物释放得到了显著控制。进行了广泛的体外和体内研究,以提出BPNP的抗癌和抗增殖活性。通过相关的体内荧光成像补充的血浆和组织分布研究描绘了静脉注射后BPNP中所含DOX的确切命运。还通过小鼠急性毒性研究生成了比较安全性概况,以明确确定BPNP的有用性。结果表明,BPNP显著增强了DOX的抗癌活性,同时由于药物的空间和时间呈现改变,减轻了其潜在毒性,因此值得进一步进行异速生长迭代。